Aarti Pharmalabs Limited — Others, 10-03-2025: ESOP/ESOS/ESPS

Aarti Pharmalabs has allotted 8,616 equity shares under its Performance Stock Option Plan 2023 (PSOP 2023) at an exercise price of Rs. 5 each, resulting in an increase of the paid-up equity share capital to Rs. 45.32 crore, with a total of 9.06 crore shares now outstanding. This move is likely to boost employee morale and align management incentives with shareholder interests. Investors may view this positively as it emphasizes the company's commitment to rewarding staff and enhancing performance, though they should remain aware of potential dilution effects.